Enodar Biologic Corporation

True Discovery

Our Technology
A sound statistical theory without a practical computational implementation is of little use in analyzing the vast amounts of data generated by genomic studies. In order to make our statistical methods readily available we have developed a bioinformatics suite called GENEPLUS™.

Enodar has recently completed development of GENEPLUS™ V.1.2. We have already licensed this technology to following institutions: Cancer Research and Biostatistics, Fred Hutchinson Cancer Research Center, Seattle Biomedical Research Institute, MetriGenix Inc., and South West Oncology Group. Meanwhile, several other institutions are currently testing GenePlus™ for possible licenses.

Gene Plus